Pharma & Biotech

Add to MyProactive

Open Orphan PLC -

Open Orphan coronavirus testing machine arrives at hVivo's east London lab

2 weeks, 3 days ago

researcher at microscope

Redx Pharma focused on cancer and fibrosis treatment

2 weeks, 3 days ago

Abbott Laboratories - Abbott Laboratories' Covid-19 antibody test approved by UK authorities

Abbott Laboratories' Covid-19 antibody test approved by UK authorities

2 weeks, 6 days ago

EKF Diagnostics -

EKF Diagnostics expects to beat forecasts following £7.7mln order for sample collection devices

2 weeks, 6 days ago

Tiziana Life Sciences -

Tiziana Life delighted with data from liver cancer treatment trials in Italy

3 weeks ago

Tiziana Life Sciences - Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma

Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma

3 weeks ago

healthcare

Open Orphan: Scaling Up, Leveraging Valuable Assets

3 weeks ago

Open Orphan PLC - Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'

Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'

3 weeks ago

Genedrive PLC - UK in talks to buy Roche’s Covid-19 antibody tests following US, EU lead

UK in talks to buy Roche’s Covid-19 antibody tests following US, EU lead

3 weeks ago

Hargreaves Lansdown PLC - Morning Report: FTSE 100 opens as Lloyd's of London expects claims to be biggest since 9/11

Morning Report: FTSE 100 down as Lloyd's of London expects claims to be biggest since 9/11

3 weeks ago

ImmuPharma PLC - Immupharma says US study shows potential for Lupuzor to reduce coronavirus symptoms

ImmuPharma surges as US study shows potential for Lupuzor to reduce coronavirus symptoms

3 weeks ago

MaxCyte Inc - Maxcyte to present clinical data from MCY-M11 phase one trial at the American Society of Clinical Oncology

Maxcyte to present clinical data from MCY-M11 phase one trial at American Society of Clinical Oncology

3 weeks ago

Tiziana Life Sciences -

Tiziana Life Sciences CEO believes breast cancer technology could become an "essential prognostic tool”

3 weeks ago

Oncimmune -

Oncimmune's study data to be featured at prestigious cancer research conference

3 weeks ago

Verona Pharma -

Verona Pharma given US regulatory go ahead for phase III programme

3 weeks ago

Tiziana Life Sciences - Tiziana's StemPrintER shown to be SUPERIOR to Exact Sciences' Oncotype DX breast cancer test

Tiziana's StemPrintER shown to be SUPERIOR to Exact Sciences' Oncotype DX breast cancer test

3 weeks ago

Atai Life Sciences - Atai Life Sciences 'bringing innovation to mental healthcare and treatment addiction'

Atai Life Sciences 'bringing innovation to mental healthcare and treatment addiction'

3 weeks, 2 days ago

Fusion Antibodies PLC - Fusion Antibodies CEO sees 'enormous value' in antibody platform as it expands to include COVID-19

Fusion Antibodies CEO sees 'enormous value' in discovery platform as it expands to include COVID-19

3 weeks, 2 days ago

Ryanair Holdings plc - Morning Report: FTSE 100 gets boost as firms announce re-start plans

Retail & consumer

Morning Report: FTSE 100 gets boost as firms announce re-start plans

3 weeks, 2 days ago

Oncimmune -

Oncimmune agrees drug development collaboration with leading US biopharma group

3 weeks, 2 days ago

Follow us on:

© Proactive Investors 2019.

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.